期刊文献+

替米沙坦对新疆哈萨克族高血压患者外周血T细胞活化增殖后电压门控钾通道的阻断作用 被引量:2

Effects of telmisartan on the voltage-gated potassium channel following T cells activation and proliferation in peripheral blood of patients with hypertension in Xinjiang Kazakh
原文传递
导出
摘要 目的探讨替米沙坦对新疆哈萨克族高血压患者外周血T细胞活化增殖后电压门控Kv1.3钾通道的阻断作用。方法 2012年8至12月在新疆医科大学第一附属医院高血压门诊随机入选未经降压药物治疗的新疆哈萨克族高血压患者30例,男女各15例。分离其外周血T细胞进行体外培养增殖。将培养增殖后T细胞不作任何处理(空白对照组)或将替米沙坦和4-氨基吡啶(Kv1.3钾通道阻滞剂)溶解后分别加入培养液中(替米沙坦组和4-氨基吡啶组),继续培养。采用膜片钳技术记录上述3组T细胞培养0、24、48h后的Kv1.3钾通道电生理特性。结果替米沙坦组干预24和48h的Kv1.3钾通道峰电流、峰值电流密度较同一时间点空白对照组降低[24h:(866±137)比(1603±379)pA,(236±32)比(443±60)pA/pF;48h:(595±149)比(1632±375)pA,(161±30)比(417±62)pA/pF,均P<0.01]。替米沙坦对T细胞Kv1.3钾通道干预24h、48h的阻断率分别为46.7%、61.4%。4-氨基吡啶组各个干预时间点的Kv1.3钾通道峰电流、峰值电流密度较空白对照组降低[0h:(443±105)比(1581±395)pA,(117±19)比(416±126)pA/pF;24h:(261±54)比(1603±379)pA,(70±12)比(443±60)pA/pF;48h:(209±55)比(1632±375)pA,(57±18)比(417±62)pA/pF,均P<0.01]。结论替米沙坦呈时间依赖性阻断新疆哈萨克族高血压患者T细胞Kv1.3钾通道。 Objective To investigate the effects of telmisartan on the voltage-gated potassium channel Kv1. 3 after T cells activation and proliferation in peripheral blood of Xinjiang Kazakh hypertensives. Methods In the Hyperten- sion Department, First Affiliated Hospital of Xinjiang Medical University, from August to December 2012, 30 Xinjiang Kazakh hypertensive outpatients ( 15 males and 15 females respectively) without antihypertensive drug ther- apy were randomly enrolled. Their peripheral blood T cells were isolated and cultured in vitro without any treat- ment( blank control group), or telmisartan and 4-aminopyridine (Kv1. 3 potassium channel blockers)were dissolved and put into the nutrient solution respectively( the telmisartan group and 4-aminopyridine group). The Kv1. 3 chan- nel electrophysiological characteristics of T cells following telmisartan or 4-aminopyridine exposure for 0, 24, 48 h were analyzed with patch-clamp techniques. Results The peak current and peak current density of Kv1. 3 channel treated with telmisartan for 24 h or 48 h were significantly inhibited as compared with the corresponding blank con- trol group [for peak current: (866±137) vs (1603±379)pA at 24 h and (595±149) vs (1632±375)pA at 48 h; for peak current density: (236±32) vs (443±60)pA/pF at 24 h and (161±30) vs (417±62)pA/pF at 48 h; all P〈 0.01]. The blocking rates after intervention with telmisartan for 24 h and 48 h were 46.7% and 61.4%, respectively. Similarly, the Kv1. 3 channel peak current and peak current density following 4-aminopyridine exposurefor various time were lower than the control group [for peak current: (443±105) vs (1581±395) at 0 h, (261±54) vs (1603±379) at 24 h and (209±55( vs (1632±375) pA at 48 h; for peak current density: (117±19) vs (416± 126) at0 h, (70±12) vs (443±60) at 24 h and (57±18) vs (417±62) pA/pF at 48 h; all P〈0.01]. Conclusions Telmisartan displayed a time-dependent inhibition on potassium channel Kv1. 3 of T cells in patients with hypertension in Xinjiang Kazakh.
出处 《中华高血压杂志》 CAS CSCD 北大核心 2014年第5期457-462,共6页 Chinese Journal of Hypertension
基金 国家自然科学基金(81160039)
关键词 高血压 T淋巴细胞 KV1 3钾通道 替米沙坦 Hypertension T-lymphocytes Kvl. 3 potassium channel Telmisartan
  • 相关文献

参考文献22

  • 1Pauletto P, Rattazzi M. Inflammation and hypertension: the search for a link[J]. Nephrol Dial Transplant,2006,21(4):850-853.
  • 2Pietri P, Vyssoulis G, Vlachopoulos C, etal. Relationship be- tween low-grade inflammation and arterial stiffness in patients with essential hypertension[J]. J Hypertens, 2006,24 ( 11 ) : 2231- 2238.
  • 3I.ewis RS, Cahalan MD. Potassium and calcium channels in lym- phocytes[J]. Annu Rev Immunol, 1995,13(7) :623-653.
  • 4Tsutsumi K, Stromberg C, Saavedra JM. Characterization of an- giotensin II receptor subtypes in the rat speen[J]. Pepfides, 1992,13(2) :291-296.
  • 5Gomez RA, Norling LL, Wilfong N, et ai. I.eukocytes synthesize angiotensinogen[J]. Hypertension, 1993,21 (4) :470-475.
  • 6Manabe S, Okura T, Watanabe S, et al. Effects of angiotensin H receptor blockade with valsartan on pro-inflammatory cytokines inpatients with essential hypertension[J]. J Cardiovasc Pharmaeol, 2005,46(6) 735-739.
  • 7戴向军,张源明,侯秀丽,罗健,魏海燕.新疆哈萨克族高血压患者外周血淋巴细胞Kv1.3通道的表达[J].中华高血压杂志,2012,20(2):175-178. 被引量:11
  • 8刘力生.中国高血压防治指南2010[J].中华高血压杂志,2011,19(8):701-708. 被引量:6982
  • 9Panyi G, Varga Z, Gdspdr R. Ion channels and lymphocyte acti- vation[J]. Immunol Lett,2004,92(1/2) :55-66.
  • 10Cahalan MD, WuIff H, Chandy KG. Molecular properties and physiological roles of ion channels in the immune system[J]. J Clin Immunol,2001,21(4) :235-252.

二级参考文献71

共引文献6998

同被引文献36

  • 1杨功焕,马杰民,刘娜,周灵妮.中国人群2002年吸烟和被动吸烟的现状调查[J].中华流行病学杂志,2005,26(2):77-83. 被引量:1061
  • 2高静,项永兵,徐望红,邵常霞,阮志贤,程家蓉,舒晓鸥,高玉堂.吸烟、饮酒与子宫内膜癌关系的病例对照研究[J].复旦学报(医学版),2006,33(1):10-16. 被引量:17
  • 3吴进寿,洪华山.高血压与炎症关系的研究进展[J].中国临床药理学与治疗学,2006,11(2):136-140. 被引量:47
  • 4陈健,陈治卿,梁立新,余玲玲,刘莉莉.原发性高血压血瘀证患者活化血小板、胰岛素抵抗及动态血压变化特点[J].中国临床康复,2006,10(15):14-16. 被引量:13
  • 5Schiffrin EL. T lymphocytes:a role in hypertension[J]. Curr OpinNephrol Hypertens,2010,19(2) : 181-186.
  • 6Harrison DG,Vinh A,Lob H, et al. Role of the adaptive im-mune system in hypertension[J]. Curr Opin Pharmacol,2010,10(2):203-207.
  • 7Guzik J, Hoch E, Brown A, et al. Role of the T cell in the gene-sis of angiotensin U -induced hypertension and vascular dysfunc-tion[J], J Exp Med,2007,204(10) ;2449-2460.
  • 8Kroigaard CI. Dal.sgaard T, Nielsen G,et al. Activation of endo-thelial and epithelial K(Ca) 2. 3 calcium-activated potassium chan-nels by NS309 relaxes human small pulmonary arteries and bron-chioles[J]. Br J Pharmacol, 2012 ,167(1) ;37-47.
  • 9Dorffel Y, Lfitsch C, Stuhlmuller B, et al. Preactivated peripher-al blood monocytes in patients with essential hypertension [ J].Hypertension, 1999,34(1) : 113-117.
  • 10Agace WW. Tissue-tropic effector T cells: generation and targe-ting opportunities[J]. Nat Rev Immunol,2006,6(9) :682-692.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部